Facebook Twitter YouTube Google Plus

Mesothelioma Genetics Project

Jill Ohar, MD
Wake Forest University School of Medicine

Jill A. Ohar, MD, is Professor of Medicine in the Section on Pulmonary, Critical Care, Allergy & Immunologic Disease, at Wake Forest University School of Medicine, Winston-Salem, North Carolina. Dr. Ohar is also Director of Clinical Operations at Wake Forest University Baptist Medical Center. She is board certified by the American Board of Internal Medicine in internal medicine, critical care medicine, and pulmonary disease.

Dr. Ohar earned her bachelor of science degree, graduating magna cum laude, from Muhlenberg College in Allentown, Pennsylvania, and her medical degree from Medical College of Pennsylvania in Philadelphia. Her postdoctoral training included an internship in obstetrics/gynecology at the Medical College of Pennsylvania and a residency in medicine at Medical College of Virginia in Richmond, where she completed a subsequent clinical fellowship in pulmonary diseases. A clinical investigator and a frequent guest lecturer, Dr. Ohar is the author or coauthor of numerous journal articles, reviews, abstracts, and book chapters. She sits on the editorial board for Journal of COPD Management and is Ad Hoc Reviewer for New England Journal of Medicine, European Respiratory Journal, American Journal of Respiratory and Critical Care Medicine, and Chest. She has published in such journals as Critical Care Medicine, Annals of Internal Medicine, and Chest, among others. She is a member of the American College of Physicians and the American Thoracic Society and a fellow of the American College of Chest Physicians.

To view the video, click on it.

Experimental Strategies in Peritoneal Mesothelioma

Experimental Strategies in Malignant Mesothelioma

Raising the Bar in Mesothelioma Research

Discovery / Progress - Mesothelioma Research and the Dept. of Defense (DoD)

Palliative Care is Not a Dirty Word

National Mesothelioma Virtual Bank

Mesothelioma Legal Panel

Mesothelioma Genetics Project

Making the Case for Federal Funding for Mesothelioma - Briefing on Capitol Hill

Government Benefits: Know Your Options

Global Perspectives in Malignant Mesothelioma

Finding Spiritual Support

Updates on Clinical Trials and Standard Therapies

Q&A Panel - Experimental Strategies in Malignant Mesothelioma

Words: Friend or Foe

Complementary and Alternative Medicine Approaches

Advocacy 101

Advancing the Mesothelioma Mission